COVID-19 impact on people with diabetes in South and Central America (SACA region)
- PMID: 32623036
- PMCID: PMC7332429
- DOI: 10.1016/j.diabres.2020.108301
COVID-19 impact on people with diabetes in South and Central America (SACA region)
Abstract
Aims: The present observational study aims to describe political actions in place to combat COVID-19 in the South and Central America region (SACA) while protecting individuals with diabetes.
Methods: A survey with 12 questions was shared with all IDF-SACA member organizations, in 18 countries. A descriptive analysis was performed and a multivariate cluster analysis technique pam (partitioning around medoids) was applied.
Results: Two groups of countries were identified. The first group, mostly countries with stricter measures to contain the spread of the virus, reported more difficulties (limitations in accessing basic or health needs) and fears (concerns regarding the impact of the pandemic); whereas most of the second group consisted of countries with less restrictive measures, and reported fewer difficulties. Only 37% responded that a policy was put into place to protect individuals with diabetes, either delivering their medicines and supplies at home (16%) or providing them at once enough for 2-3 months (21%). All respondents reported that one of the main fear was to "be infected and not to receive adequate treatment" and/or "getting infected if going to the hospital or medical appointments".
Conclusion: Most of the SACA countries failed to implement timely measures to protect individuals with diabetes, which may severely impact individuals, health systems and economies.
Keywords: COVID-19; Central America; Diabetes; Pandemic; SARS-CoV-2; South America.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Comment in
-
The COVID-19 pandemic substantially complicates the usual challenges for patients with diabetes in Latin America.Diabetes Res Clin Pract. 2020 Oct;168:108394. doi: 10.1016/j.diabres.2020.108394. Epub 2020 Aug 29. Diabetes Res Clin Pract. 2020. PMID: 32866555 Free PMC article. No abstract available.
References
-
- Rodriguez-Morales A.J., Sánchez-Duque J.A., Hernández Botero S., Pérez-Díaz C.E., Villamil-Gómez W.E., Méndez C.A., Verbanaz S., Cimerman S., Rodriguez-Enciso H.D., Escalera-Antezana J.P., Balbin-Ramon G.J., Arteaga-Livias K., Cvetkovic-Vega A., Orduna T., Savio-Larrea E., Paniz-Mondolfi A., LANCOVID-19 Preparación y control de la enfermedad por coronavirus 2019 (COVID-19) en América Latina. Acta Med Peru. 2020;37(1):3–7. doi: 10.35663/amp.2020.371.909. http://amp.cmp.org.pe/index.php/AMP/article/view/909 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
